Mankind Pharma Ltd has allotted three series of Non-Convertible Debentures (NCDs) totaling INR 62.5 billion with varying tenures and an interest rate of approximately 7.97% to 7.99%. The debentures are listed and secured, with maturities ranging from 18 to 37 months from the date of allotment (October 16, 2024).